about
Cancer immunotherapy in veterinary medicine: Current options and new developments.Primary primitive neuroectodermal tumors of the retina and ciliary body in dogs.Autophagy Inhibition Delays Early but Not Late-Stage Metastatic Disease.Do Mesenchymal Stromal Cells Influence Microscopic Residual or Metastatic Osteosarcoma in a Murine Model?Clinicopathologic findings in a dog with a retrobulbar meningioma.Activated Mesenchymal Stem Cells Interact with Antibiotics and Host Innate Immune Responses to Control Chronic Bacterial Infections.Immune regulation of canine tumour and macrophage PD-L1 expression.Immunization against full-length protein and peptides from the Lutzomyia longipalpis sand fly salivary component maxadilan protects against Leishmania major infection in a murine model.Manipulation of Innate Immunity for Cancer Therapy in Dogs.Mesenchymal Stem Cells Recruit CCR2+ Monocytes To Suppress Allergic Airway Inflammation.Diet-induced obesity causes visceral, but not subcutaneous, lymph node hyperplasia via increases in specific immune cell populations.Role of monocyte recruitment in hemangiosarcoma metastasis in dogs.Canine sarcomas as a surrogate for the human disease.Safety and immune regulatory properties of canine induced pluripotent stem cell-derived mesenchymal stem cells.Regulation of PD-L1 expression on murine tumor-associated monocytes and macrophages by locally produced TNF-α.Mechanisms of Immune Suppression Utilized by Canine Adipose and Bone Marrow-Derived Mesenchymal Stem Cells.Suppression of Canine Dendritic Cell Activation/Maturation and Inflammatory Cytokine Release by Mesenchymal Stem Cells Occurs Through Multiple Distinct Biochemical Pathways.Adipose tissue extrinsic factor: Obesity-induced inflammation and the role of the visceral lymph node.The Angiotensin Receptor Blocker Losartan Suppresses Growth of Pulmonary Metastases via AT1R-Independent Inhibition of CCR2 Signaling and Monocyte Recruitment.Characterization of cytokines associated with Th17 cells in the eyes of horses with recurrent uveitisBony ingrowth potential of 3D-printed porous titanium alloy: a direct comparison of interbody cage materials in an in vivo ovine lumbar fusion modelBigger Is Better: Refinement of an Animal Model of Hepatocellular Carcinoma and Transfemoral Arterial EmbolizationCharacterization of an Inducible Alcoholic Liver Fibrosis Model for Hepatocellular Carcinoma Investigation in a Transgenic Porcine Tumorigenic PlatformFirst-in-Class Inhibitors of Oncogenic CHD1L With Preclinical Activity Against Colorectal Cancer
P50
Q34500896-9B0A00F7-9EDB-4914-AD35-7EDEA4934AA6Q34723795-D6C00639-8974-4E8E-8F66-4A1066D88F9DQ36031947-1EEA1425-ADCA-421C-A1D6-F26BE2A2CA9BQ36558616-32A47C4E-1567-4849-9A6F-0374918AE6B7Q37930291-4F1560D7-71A4-4871-8098-F1164F2496ADQ40075675-15FBE209-2475-4E27-9B12-7AA6714FD70AQ42488567-87B864F4-CB28-4496-B12C-0FD54C4713C4Q47094812-9F0CB61A-8B4D-45BF-972B-A2B3175AD8E9Q47137850-1B448651-B5BF-4CB5-AD5F-4D88DA805B91Q48204969-6DE7B288-763A-4E5F-826D-6011BC4D1C50Q48314976-A6476DC2-6623-416F-AB68-B3E496698E70Q48957796-BA7A5215-016E-4CB0-8CFF-6DCF3EDAB21FQ49602648-9E046195-3E48-4C38-B211-AF48FFC800C5Q49677594-7056E791-8C9F-4A06-983C-12270419A079Q51142916-9A97BF48-1A57-480F-8926-CD838565C0BBQ51307397-5F053839-8E01-46DB-9AB2-54DEE68B2A22Q51328073-A1F5B52D-B446-4CAC-8645-C79CA33BCEC2Q52368386-FC4E7FDB-91E4-48D1-A05E-7550767B86CCQ64947170-D9D073CF-5685-4AA5-A3E6-E82236511398Q82332276-79753F65-6746-4F84-9C6C-4798527731E1Q87928487-708E24F3-AFA4-41F7-A6A5-5D9ADBD9368EQ88378977-E61FA621-2605-4C95-A773-E5DA4060240AQ89054605-39F1C714-18B0-41AD-B7E4-FF3AA0B48426Q96134293-A2245A3C-1A8F-4066-8302-23CBF6AA239D
P50
description
researcher ORCID ID = 0000-0002-3148-1332
@en
name
Daniel Regan
@ast
Daniel Regan
@en
Daniel Regan
@es
Daniel Regan
@nl
type
label
Daniel Regan
@ast
Daniel Regan
@en
Daniel Regan
@es
Daniel Regan
@nl
prefLabel
Daniel Regan
@ast
Daniel Regan
@en
Daniel Regan
@es
Daniel Regan
@nl
P21
P31
P496
0000-0002-3148-1332